Theralase Technologies Inc.
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
Theralase Technologies Inc. made a loss over the last year. Theralase Technologies Inc. owes C$0.16 for every C$1 it owns. Theralase Technologies Inc. made a loss in each of the last two years.
Compared with Healthcare companies in Canada · latest annual results Dec 2025.
P/E ratio
LossTheralase Technologies Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
9.08The share price is 9.08 times Theralase Technologies Inc.'s book value per share, higher than 85% of Healthcare companies in Canada.
Market cap
C$62 MThe total market value of all of Theralase Technologies Inc.'s shares at today's price (share price × number of shares), larger than 65% of Healthcare companies in Canada. PosiCap size class: Micro Cap.
Net worth (book value)
C$7 MWhat Theralase Technologies Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
C$0.02Net worth divided by the number of shares. The share price of C$0.20 is 9.1 times this, which is the P/B above.
Return on equity (ROE)
-93.4%Theralase Technologies Inc. lost 93.4% of its shareholders' money over the last year, lower than 77% of Healthcare companies in Canada.
Owes vs Owns
0.16×Theralase Technologies Inc. owes C$0.16 for every C$1 it owns (low), lower than 88% of Healthcare companies in Canada.
Dividend yield
NoneTheralase Technologies Inc. does not currently pay a dividend.
Revenue growth
-21%Revenue fell 21% in the year to Dec 2025, and shrank 10% a year on average over 3 years.
Profit growth
LossTheralase Technologies Inc. made a loss in each of the last two years.
Profit margin
-504.7%Theralase Technologies Inc. lost C$505 for every C$100 of revenue.
Interest cover
Not coveredTheralase Technologies Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.
Cash vs debt
Net debtTheralase Technologies Inc. had C$0 M more debt than cash (net debt) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Theralase Technologies Inc.: C$62 M ÷ C$7 M (30 Jun 2026) = 9.1.
What is Theralase Technologies Inc.'s return on equity?
Theralase Technologies Inc. lost 93.4% of its shareholders' money over the last year, lower than 77% of Healthcare companies in Canada.
How much does Theralase Technologies Inc. owe compared with what it owns?
Theralase Technologies Inc. owes C$0.16 for every C$1 it owns (low), lower than 88% of Healthcare companies in Canada.
Does Theralase Technologies Inc. pay a dividend?
No. Theralase Technologies Inc. does not currently pay a dividend.
Is Theralase Technologies Inc.'s revenue growing?
Revenue fell 21% in the year to Dec 2025, and shrank 10% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.